MacroGenics Inc
MGNX
$3.74-1.58%
End of day · as of Sep 27, 2026, 2:30 PM ET
Mkt cap
$246.62M
EV/Sales
1.27
P/E ratio
N/A
FY2025 Revenue
$149.50M
EPS (TTM)
$-0.22
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-49.91%
Beta
N/A
Div yield
N/A
Sector
Healthcare
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported MGNX revenue for 2025-12-31 was $149.5M. Net income was -$74.6M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. MGNX currently screens at market cap $246.6M.
Use this MGNX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MGNX income, balance, and cash tables.
MacroGenics Inc (MGNX) is a biotechnology company in the Healthcare sector.
Latest cached MacroGenics Inc (MGNX) revenue for Dec 31, 2025 was $149.5M. Net income was -$74.6M. Statements: https://lician.com/financials/mgnx
MacroGenics Inc (MGNX) market capitalization is $246.6M on the latest cached snapshot.
MacroGenics Inc (MGNX) cached previous close $3.80; day range $3.72 – $3.86; volume 603,460. Session quote: https://lician.com/quote/mgnx
MacroGenics Inc (MGNX) latest cached earnings event is "MGNX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MGNX filing is 8-K/A · Sep 3, 2026. Filings: https://lician.com/sec/mgnx